Episode 13 – Multiplexing with Dr Luke Gammon, Queen Mary University & Dr David Pointu, Leica Microsystems
Posted: 28 September 2022 | Drug Target Review | No comments yet
Join our experts as they discuss the advantages of multiplexed imaging for a wide range of research and how this technique will develop in the future.
DOWNLOAD MULTIPLEXING GLOSSARY
In this episode of Drug Target Review’s podcast, sponsored by Leica Microsystems, Dr Luke Gammon, Screening Core Facility Manager at Queen Mary University of London, UK discusses multiplexed imaging with Dr David Pointu, Senior Application Specialist at Leica Microsystems.
Tune in to this podcast to understand how multiplexing can provide an advanced imaging technique, the benefits of this method and how data is examined and shared with end users, plus much more!
Key learning points:
- How experts utilise multiplexing in their research
- The advantages of this imaging method in comparison to other techniques
- What samples can be analysed using this platform
- What the future is for multiplexing research.
Make sure you don’t miss any new podcasts from Drug Target Review – sign up here to be notified of releases!
Dr Luke Gammon, Screening Core Facility Manager at Queen Mary University of London
Dr David Pointu, Senior Application Specialist at Leica Microsystems
Related topics
Analysis, Analytical Techniques, Biomarkers, Drug Targets, Imaging, Research & Development, Structural Biology, Technology
Related organisations
Leica Microsystems, Queen Mary University of London
Related people
Dr David Pointu, Dr Luke Gammon